Sign up to save your podcasts
Or
Share Episode 98: Navigating Chronic Urticaria - A Panel Discussion from the 2025 Annual SF Derm Conference | The Future of Dermatology
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 98: Navigating Chronic Urticaria - A Panel Discussion from the 2025 Annual SF Derm Conference | The Future of Dermatology
Summary
In this truncated replay from a session at the 2025 SF Derm Annual Conference, Dr. Daniel Butler, Dr. Lawrence Eichenfield, Dr. Jason Hawkes, Dr. Shyam Joshi, and Dr. Bob Geng discuss the workup for chronic urticaria, focusing on testing approaches, the role of biomarkers, and insights into immune deficiencies. These panelists share their experiences and guidelines, emphasizing the importance of symptomatic management and the variability of lab results in clinical practice.
Takeaways
- Initial workup for chronic urticaria often does not require specific testing.
- Testing may be justified if standard treatments fail.
- International guidelines differ from US guidelines regarding testing.
- Biomarkers currently available are not reliable for treatment decisions.
- Symptomatic management should be prioritized over extensive testing.
- Clinical trials show variability in lab results over time.
- Excessive lab testing can lead to confusion and unnecessary anxiety for patients.
- Understanding patient history is crucial in diagnosing immune deficiencies.
- The role of family history is significant in identifying X-linked conditions.
- Collaboration among dermatologists is essential for advancing treatment approaches.
Chapters
00:00 - Introduction to Chronic Urticaria Workup
02:47 - Testing Approaches and Guidelines for Chronic Urticaria
05:41 - The Role of Biomarkers in Treatment Decisions
08:16 - Clinical Insights on Immune Deficiencies
11:14 - Variability in Lab Results and Clinical Trials
14:07 - Conclusion and Future Directions in Dermatology
View all episodes
By thefutureofdermatology
5
44 ratings
Summary
In this truncated replay from a session at the 2025 SF Derm Annual Conference, Dr. Daniel Butler, Dr. Lawrence Eichenfield, Dr. Jason Hawkes, Dr. Shyam Joshi, and Dr. Bob Geng discuss the workup for chronic urticaria, focusing on testing approaches, the role of biomarkers, and insights into immune deficiencies. These panelists share their experiences and guidelines, emphasizing the importance of symptomatic management and the variability of lab results in clinical practice.
Takeaways
- Initial workup for chronic urticaria often does not require specific testing.
- Testing may be justified if standard treatments fail.
- International guidelines differ from US guidelines regarding testing.
- Biomarkers currently available are not reliable for treatment decisions.
- Symptomatic management should be prioritized over extensive testing.
- Clinical trials show variability in lab results over time.
- Excessive lab testing can lead to confusion and unnecessary anxiety for patients.
- Understanding patient history is crucial in diagnosing immune deficiencies.
- The role of family history is significant in identifying X-linked conditions.
- Collaboration among dermatologists is essential for advancing treatment approaches.
Chapters
00:00 - Introduction to Chronic Urticaria Workup
02:47 - Testing Approaches and Guidelines for Chronic Urticaria
05:41 - The Role of Biomarkers in Treatment Decisions
08:16 - Clinical Insights on Immune Deficiencies
11:14 - Variability in Lab Results and Clinical Trials
14:07 - Conclusion and Future Directions in Dermatology
More shows like The Future of Dermatology
View all
How I Built This with Guy Raz
30,226 Listeners
JDD Podcast: Ask the Investigator
67 Listeners
The Daily
112,572 Listeners
The Peter Attia Drive
8,651 Listeners
Dermasphere - The Dermatology Podcast
135 Listeners
The Passive Income MD Podcast
278 Listeners
Huberman Lab
29,146 Listeners
Derms and Conditions
51 Listeners
The Dermalorian Podcast
6 Listeners
Derms on Drugs
32 Listeners